Physiological Effect: Increased Glutathione Concentration
✉ Email this page to a colleague
Drugs with Physiological Effect: Increased Glutathione Concentration
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alvogen | ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 204674-001 | Feb 11, 2014 | AN | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Am Regent | ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 072489-001 | Jul 28, 1995 | AN | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Zydus Pharms | ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 208166-001 | Jul 20, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Fresenius Kabi Usa | ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 200644-001 | Nov 7, 2012 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |